| Variables | Efficacy | Total (n = 525) | P value | ||
| Inefficient (n = 201) | Improved (n = 225) | Cured (n = 99) | |||
| Age, yr | 58.6 ± 19.8 | 61.6 ± 19.5 | 53.9 ± 18.8 | 59.0 ± 19.6 | 0.003 |
| Cr, μmol·L−1 | 73.7 ± 24.8 | 78.8 ± 26.8 | 70.9 ± 20.5 | 75.5 ± 25.1 | 0.013 |
| BUN, mmol·L−1 | 5.5 ± 2.4 | 5.5 ± 2.5 | 4.8 ± 2.0 | 5.4 ± 2.4 | 0.023 |
| ALT, U·L−1 | 21.5 ± 16.1 | 21.2 ± 14.2 | 22.3 ± 17.4 | 21.5 ± 15.5 | 0.836 |
| AST, U·L−1 | 21.7 ± 11.3 | 22.7 ± 13.7 | 21.8 ± 13.1 | 22.2 ± 12.8 | 0.697 |
| Duration of Anti-Infection Treatment | 0.791 | ||||
| ≤3 | 28 | 48 | 20 | 96 | 0.765 |
| 4 - 7 | 91 | 128 | 55 | 274 | |
| 8+ | 51 | 63 | 35 | 149 | |
| Sort of Medicine | <0.001 | ||||
| Moxifloxacin | 48 | 66 | 32 | 146 | |
| Levofloxacin | 64 | 130 | 62 | 256 | |
| Ciprofloxacin | 10 | 22 | 8 | 40 | |
| Fleroxacin | 11 | 10 | 4 | 25 | |
| Lomefloxacin | 37 | 11 | 4 | 52 | |
| Site of Infection | <0.001 | ||||
| Respiratory System Infection | 57 | 125 | 54 | 236 | |
| Urological System Infection | 19 | 38 | 19 | 80 | |
| Digestive System Infection | 14 | 25 | 19 | 58 | |
| Other Infection | 46 | 22 | 7 | 75 | |
| Mixed Infection | 34 | 29 | 7 | 70 | |
| Gender | 0.186 | ||||
| Male | 98 | 139 | 53 | 290 | |
| Female | 72 | 100 | 57 | 229 | |
| History of Smoking | 0.264 | ||||
| No | 150 | 197 | 92 | 439 | |
| Yes | 20 | 42 | 18 | 80 | |
| History of Drinking | 0.268 | ||||
| No | 162 | 221 | 106 | 489 | |
| Yes | 8 | 18 | 4 | 30 | |